Anonymous: "JPET peeves: Paper withdrawn after drug company won't disclose chemical structure - Retraction Watch at Retraction Watch", , 1 January 2012 (2012-01-01), XP55341012, Retrieved from the Internet: URL:http://retractionwatch.com/2012/06/20/ jpet-peeves-paper-withdrawn-after-drug-com pany-wont-disclose-chemical-structure/ [retrieved on 2017-02-01] (B1)

YAN ZHANG ET AL: "Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.", CHINESE MEDICAL JOURNAL, vol. 120, no. 11, 1 June 2007 (2007-06-01) , pages 988-995, XP55117201, ISSN: 0366-6999 (B1)

CHUN-GYOO IHM ET AL: "Effects of therapeutic agents on the inflammatory and fibrogenic factors in IgA nephropathy", NEPHROLOGY, vol. 12, no. s3, 1 December 2007 (2007-12-01), pages S25-S26, XP055118254, ISSN: 1320-5358, DOI: 10.1111/j.1440-1797.2007.00878.x (B1)

EP-A1- 1 422 228 (B1)

HORUK R: "Chemokine receptor antagonists: overcoming developmental hurdles", NATURE REVIEWS. DRUG DISCOVERY, NATURE PUBLISHING GROUP, GB, vol. 8, 1 January 2009 (2009-01-01), pages 23-33, XP007909904, ISSN: 1474-1784 (B1)

KANA TSUKUDA ET AL.: 'Irbesartan attenuates ischemic brain damage by inhibition of MCP-I/CCR2 signalling pathway beyond AT1, receptor blockade' BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS vol. 409, 07 May 2011, pages 275 - 279, XP028375638 (B1)

KANAMORI H ET AL: "Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 360, no. 4, 7 September 2007 (2007-09-07), pages 772-777, XP025989996, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2007.06.148 [retrieved on 2007-09-07] (B1)

MAKI URUSHIHARA ET AL.: 'Addition of Angiotensin II Type 1 Receptor Blocker to CCR2 Antagonist Markedly Attenuates Crescentic Glomerulonephritis' HYPERTENSION vol. 57, no. 3, March 2011, pages 586 - 593, XP055111514 (B1)

MASAYO NAITO ET AL: "High Ambient Glucose Augments Angiotensin II-Induced Proinflammatory Gene mRNA Expression in Human Mesangial Cells: Effects of Valsartan and Simvastatin", AMERICAN JOURNAL OF NEPHROLOGY, vol. 30, no. 2, 1 January 2009 (2009-01-01), pages 99-111, XP55117240, ISSN: 0250-8095, DOI: 10.1159/000203619 (B1)

MINGDE XIA ET AL: "Recent developments in CCR2 antagonists", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, UNITED KINGDOM, vol. 19, no. 3, 1 March 2009 (2009-03-01), pages 295-303, XP002660853, ISSN: 1744-7674, DOI: 10.1517/13543770902755129 (B1)

Q DAI ET AL: "Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats", BRITISH JOURNAL OF PHARMACOLOGY, vol. 152, no. 7, 29 December 2007 (2007-12-29), pages 1042-1048, XP55117185, ISSN: 0007-1188, DOI: 10.1038/sj.bjp.0707454 (B1)

SHUEI-LIONG LIN ET AL: "Effect of Pentoxifylline in Addition to Losartan on Proteinuria and GFR in CKD: A 12-Month Randomized Trial", AMERICAN JOURNAL OF KIDNEY DISEASES, vol. 52, no. 3, 1 September 2008 (2008-09-01), pages 464-474, XP55117191, ISSN: 0272-6386, DOI: 10.1053/j.ajkd.2008.05.012 (B1)

STRUTHERS M ET AL: "CCR2 Antagonists", CURRENT TOPICS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS LTD, HILVERSUM; NL, vol. 10, no. 13, 1 January 2010 (2010-01-01), pages 1278-1298, XP002641076, ISSN: 1568-0266 (B1)

TAKUYA OKADA ET AL: "Combined Treatment With Valsartan and Spironolactone Prevents Cardiovascular Remodeling in Renovascular Hypertensive Rats", INTERNATIONAL HEART JOURNAL, vol. 47, no. 5, 1 September 2006 (2006-09-01), pages 783-793, XP55117421, ISSN: 1349-2365, DOI: 10.1536/ihj.47.783 (B1)

TERRY C MAJOR ET AL: "A CCR2/CCR5 Antagonist Attenuates an Increase in Angiotensin II-Induced CD11b+ Monocytes from Atherogenic ApoEâ /â Mice", CARDIOVASCULAR DRUGS AND THERAPY, KLUWER ACADEMIC PUBLISHERS, BOSTON; US, vol. 23, no. 2, 4 December 2008 (2008-12-04), pages 113-120, XP019671858, ISSN: 1573-7241 (B1)

US-A- 5 492 904 (B1)

US-A- 5 663 188 (B1)

WO-A1-2006/029349 (B1)

WO-A1-2008/113095 (B1)

WO-A1-2009/042193 (B1)

WO-A1-2009/125168 (B1)

WO-A1-2010/108232 (B1)

WO-A2-2008/000421 (B1)

WO-A2-2008/060621 (B1)

WO-A2-2009/073683 (B1)

WO-A2-2010/065069 (B1)

WO-A2-96/40258 (B1)

YAFA NAIM ABU NABAH ET AL.: 'CXCR2 Blockade Impairs Angiotensin II-Induced CC Chemokine Synthesis and Mononuclear Leukocyte Infiltration' ARTERIOSCLEROSIS, THROMBOSIS AND VASCULAR BIOLOGY vol. 27, 2007, pages 2370 - 2376, XP055111511 (B1)

BYOUNG-SOO CHO ET AL: "Effects of Bupleurum falcatum and its combination with an angiotensin II receptor blocker on cytokine and chemokine expression in human mesangial cells", PHYTOTHERAPY RESEARCH, vol. 24, no. 3, 1 March 2010 (2010-03-01), pages 339-343, XP55117238, ISSN: 0951-418X, DOI: 10.1002/ptr.2936 (B1)